Literature DB >> 2885713

Enzymatic diagnosis of sphingolipidoses.

K Suzuki.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 2885713     DOI: 10.1016/0076-6879(87)38063-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  14 in total

1.  Structural basis of the GM2 gangliosidosis B variant.

Authors:  Fumiko Matsuzawa; Sei-ichi Aikawa; Hitoshi Sakuraba; Hoang Thi Ngoc Lan; Akemi Tanaka; Kousaku Ohno; Yuko Sugimoto; Haruaki Ninomiya; Hirofumi Doi
Journal:  J Hum Genet       Date:  2003-10-24       Impact factor: 3.172

2.  Direct tandem mass spectrometric profiling of sulfatides in dry urinary samples for screening of metachromatic leukodystrophy.

Authors:  Ladislav Kuchař; Befekadu Asfaw; Helena Poupětová; Jitka Honzíková; František Tureček; Jana Ledvinová
Journal:  Clin Chim Acta       Date:  2013-07-06       Impact factor: 3.786

3.  Hexosaminidase assays.

Authors:  Michaela Wendeler; Konrad Sandhoff
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

4.  Establishment of immortalized Schwann cells from Sandhoff mice and corrective effect of recombinant human beta-hexosaminidase A on the accumulated GM2 ganglioside.

Authors:  Mai Ohsawa; Masaharu Kotani; Youichi Tajima; Daisuke Tsuji; Yasuhiro Ishibashi; Aya Kuroki; Kohji Itoh; Kazuhiko Watabe; Kazunori Sango; Shoji Yamanaka; Hitoshi Sakuraba
Journal:  J Hum Genet       Date:  2005-09-23       Impact factor: 3.172

5.  Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model.

Authors:  Keisuke Kitakaze; Yasumichi Mizutani; Eiji Sugiyama; Chikako Tasaki; Daisuke Tsuji; Nobuo Maita; Takatsugu Hirokawa; Daisuke Asanuma; Mako Kamiya; Kohei Sato; Mitsutoshi Setou; Yasuteru Urano; Tadayasu Togawa; Akira Otaka; Hitoshi Sakuraba; Kohji Itoh
Journal:  J Clin Invest       Date:  2016-03-28       Impact factor: 14.808

6.  Metachromatic leukodystrophy: Biochemical characterization of two (p.307Glu→Lys, p.318Trp→Cys) arylsulfatase A mutations.

Authors:  Adem Özkan; Hatice Asuman Özkara
Journal:  Intractable Rare Dis Res       Date:  2016-11

7.  Different attenuated phenotypes of GM2 gangliosidosis variant B in Japanese patients with HEXA mutations at codon 499, and five novel mutations responsible for infantile acute form.

Authors:  Akemi Tanaka; Lan Thi Ngcok Hoang; Yasuaki Nishi; Satoshi Maniwa; Makio Oka; Tsunekazu Yamano
Journal:  J Hum Genet       Date:  2003-10-18       Impact factor: 3.172

8.  Mutations in acid beta-galactosidase cause GM1-gangliosidosis in American patients.

Authors:  R M Boustany; W H Qian; K Suzuki
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

9.  GM1-gangliosidosis (genetic beta-galactosidase deficiency): identification of four mutations in different clinical phenotypes among Japanese patients.

Authors:  J Nishimoto; E Nanba; K Inui; S Okada; K Suzuki
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

Review 10.  Diagnosis of inherited metabolic disorders affecting the nervous system.

Authors:  P D Swanson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.